Identification and Validation of PIK3CA as a Marker Associated with Prognosis and Immune Infiltration in Renal Clear Cell Carcinoma

BACKGROUND: Kidney renal clear cell carcinoma (KIRC) is the most prevalent renal malignancy. The therapeutic strategies for advanced KIRC are very few, with only sunitinib being widely approved. Mutations in the PIK3CA gene can affect tumor cell proliferation, metastasis, and patients' survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ya, Wang, Chong, Gao, Yang, Zhou, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337125/
https://www.ncbi.nlm.nih.gov/pubmed/34367282
http://dx.doi.org/10.1155/2021/3632576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337125/
https://www.ncbi.nlm.nih.gov/pubmed/34367282
http://dx.doi.org/10.1155/2021/3632576

Ejemplares similares